Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease

Not Applicable

Completed

• Conditions: Dry Eye
• Interventions: Drug: Sodium hyaluronate eye drops; Other: acupuncture

• Registration Number: NCT04668131
• Lead Sponsor: Peking University Third Hospital

Brief Summary

This project is designed as a prospective, randomized, open, controlled clinical trial. For the first time, acupuncture was applied to the treatment of dry ocular neuropathic pain. Its mechanism was discussed by comparing the efficacy between acupuncture and artificial tears.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-09
• Study Start: 2020-09-22
• Study First Submitted: 2020-12-06
• Study First Submitted QC: 2020-12-14
• Study First Posted: 2020-12-16
• Primary Completion: 2022-03-30
• Study Completion: 2022-06-30
• Last Update Submitted: 2022-11-20
• Last Update Posted: 2022-11-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• According to the DEWS diagnostic criteria, the OSDI score ≥ 13, with positive signs of dry eye (SIt ≤ 10mm/5min or TBUT ≤ 10s) or CFS positive;
• VAS>0;
• Signed informed consent.

Read More

Exclusion Criteria

• Patients with dry eye who have had irritants directly irritating the ocular surface in the past 3 days;
• Eyeball infections, allergies, deformities, abnormal movements
• Any history of eye surgery
• Have had eye trauma or fundus laser treatment within 3 months
• Used drugs that affect tear production such as antihistamines, antidepressants, etc. within 30 days
• Suffer from systemic diseases that affect tear production, including Sjogren's syndrome, diabetes, mental illness, malignant tumors, etc.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Artificial tears	Sodium hyaluronate eye drops	Artificial tears
Acupuncture	acupuncture	Acupuncture

Primary Outcome Measures

Name	Time	Method
Visual Analogue Score	The treatment period for each enrolled subject is one month	Ask the patient to mark the corresponding position on the ruler that can represent the pain or discomfort during the onset

Secondary Outcome Measures

Name	Time	Method
OSDI	The treatment period for each enrolled subject is one month	OSDI consists of 12 scoring items, divided into three parts: severity of symptoms, impact of symptoms on daily life, and impact of environment on symptoms.
TBUT	The treatment period for each enrolled subject is one month	Drop 1 drop of 0.3% sodium fluorescein eye solution into the subject's conjunctival sac, dry it with a sterile cotton swab, and ask him to blink gently to make the fluorescein sodium evenly distributed. Observe the subject from the last time with a slit lamp cobalt blue light. The time from blinking to the first dark spot on the corneal surface, record three times and take the average
SIt	The treatment period for each enrolled subject is one month	Fold one end of the special 5mm×35mm filter paper (Tianjin Jingming) for tears by 5mm, and gently place it on the middle and outer 1/3 of the subject's lower eyelid conjunctival sac, and the other end will droop naturally. Ask the subject to gently close their eyes for 5 minutes After measuring the length of the filter paper wetted by tears
CFS score	The treatment period for each enrolled subject is one month	Divide the cornea into 5 quadrants (central + nose/temporal/upper/lower), each quadrant has a staining score of 0 to 3 points, and it is specified that no staining is 0 points, and 30 spots are stained as 1 point, and there is flaky staining and fusion 3 points for filament formation, 2 points between the two, the sum of 5 quadrants is the score of the entire cornea, and the CFS score of the entire cornea is 0-15 points.
Density and curvature of corneal subbasal nerve	The treatment period for each enrolled subject is one month	Collect corneal subbasal nerve images, 2 images each in the upper, lower, arm, temporal and central areas. Use deep learning methods to analyze nerve density and curvature
Tear pain factor content	The treatment period for each enrolled subject is one month	With the aid of a slit lamp, a capillary pipette was used to draw 5 μl tears/eye at the middle and outer edges of the lower eyelid 2/3 of the tear river, and placed in a low protein adhesion EP tube (containing 5 μl 1% BSA) and stored at -80°C. ELISA analyzes the protein levels of PGE2, substance P and NGF in tear fluid.

Trial Locations

Locations (1)

Peking University Third Hospital; 🇨🇳 Beijing, China